Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EHC 2022
AES 2022
WSC 2022
ECTRIMS 2022
EHDN 2022
MDS 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Multiple Sclerosis and Related Disorders
1:56
Challenging clinical decisions in pregnancy planning with MS and NMOSD patients
Melinda Magyari
• 28 Oct 2022
1:45
Comparison of unwrapped phase and QSM for paramagnetic rim lesion detection in MS
Cristina Granziera
• 28 Oct 2022
1:49
The pathology of MS and MOGAD: similarities and differences
Hans Lassmann
• 27 Oct 2022
1:26
Current treatment guidelines: pregnancy in MS and NMOSD
Melinda Magyari
• 28 Oct 2022
1:45
Future research options in polypharmacy associated with multiple sclerosis
Anibal Chertcoff
• 28 Oct 2022
1:33
Pregnancy and infant outcomes in women with MS receiving ocrelizumab
Celia Oreja-Guevara
• 28 Oct 2022
1:29
Current challenges in MS neuroimaging
Cristina Granziera
• 28 Oct 2022
2:35
Spinal cord reserve: validation of SCaA-SCT in a prospective cohort of MS patients
Jaume Sastre-Garriga
• 28 Oct 2022
1:23
Implementing MS imaging biomarkers into everyday practice
Cristina Granziera
• 28 Oct 2022
2:55
The immune mechanisms behind neurodegeneration in progressive MS
Hans Lassmann
• 27 Oct 2022
1:10
Limitations of MS treatment guidelines
Eva Kubala Havrdová
• 27 Oct 2022
2:07
Impacts of polypharmacy on MS patients’ outcomes
Anibal Chertcoff
• 28 Oct 2022
1:05
Challenges in MS management: individualized treatments
Eva Kubala Havrdová
• 27 Oct 2022
6:12
Population-based study on polypharmacy and multiple sclerosis
Anibal Chertcoff
• 28 Oct 2022
1:46
Deciding on a tailored treatment strategy for MS patients
Eva Kubala Havrdová
• 27 Oct 2022
1:22
Protective and pro-inflammatory lipid mediators in MS
Gijs Kooij
• 27 Oct 2022
Previous
1
2
3
4
5
6
7
8
9
…
37
Next